Intercept Pharmaceuticals, Inc. (ICPT)
Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)
19.00
0.00 (0.00%)
Inactive · Last trade price
on Nov 7, 2023
Intercept Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | -61.61 | 221.82 | -91.43 | -274.88 | -344.68 | -309.24 | Upgrade
|
| Depreciation & Amortization | 0.38 | 0.59 | 2.81 | 2.94 | 3.66 | 4.58 | Upgrade
|
| Other Amortization | 1.36 | 2.61 | 33.33 | 28.5 | 23.32 | 15.57 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 2.68 | 1.33 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 2.4 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.51 | -0.63 | 4.67 | 4.01 | -0.3 | -0.03 | Upgrade
|
| Stock-Based Compensation | 24.01 | 21.89 | 28.03 | 49.19 | 55.98 | 49.91 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | -0 | 0 | 0.05 | - | - | Upgrade
|
| Other Operating Activities | 8.41 | -304.33 | -56.73 | 6.75 | 3.39 | - | Upgrade
|
| Change in Accounts Receivable | -6.32 | 1.48 | -3.42 | -1.79 | -12.35 | -9.19 | Upgrade
|
| Change in Inventory | 1.09 | 0.6 | 0.38 | 0.21 | -1.35 | -3.63 | Upgrade
|
| Change in Accounts Payable | -13.15 | 23.29 | -13.79 | -4.95 | 56.41 | 10.33 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -2.43 | -2.02 | Upgrade
|
| Change in Other Net Operating Assets | -6.93 | -3.45 | -2.87 | -8.23 | -20.94 | 1.66 | Upgrade
|
| Operating Cash Flow | -63.02 | -26.78 | -41.07 | -171.86 | -236.61 | -240.71 | Upgrade
|
| Capital Expenditures | 0.19 | -0.57 | -0.4 | -3.89 | -1.14 | -0.17 | Upgrade
|
| Investment in Securities | 167.08 | -100.82 | 71.12 | 166.71 | -187.85 | -47.9 | Upgrade
|
| Other Investing Activities | -6.16 | 363.23 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 161.11 | 261.85 | 70.73 | 162.82 | -188.99 | -48.07 | Upgrade
|
| Long-Term Debt Issued | - | - | 116.79 | - | 223.42 | - | Upgrade
|
| Long-Term Debt Repaid | - | -268.41 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -116.87 | -268.41 | 116.79 | - | 223.42 | - | Upgrade
|
| Issuance of Common Stock | 1.33 | 1.68 | 0.02 | 1.3 | 236.25 | 265.73 | Upgrade
|
| Repurchase of Common Stock | -0.43 | -0.56 | -77.56 | -1.99 | -2.16 | -2.18 | Upgrade
|
| Other Financing Activities | - | -0.04 | -38.13 | - | - | - | Upgrade
|
| Financing Cash Flow | -115.97 | -267.32 | 1.12 | -0.69 | 457.52 | 263.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.36 | -6.3 | -2.02 | 0.61 | -0.39 | -1.53 | Upgrade
|
| Net Cash Flow | -16.52 | -38.55 | 28.76 | -9.13 | 31.53 | -26.77 | Upgrade
|
| Free Cash Flow | -62.83 | -27.35 | -41.46 | -175.76 | -237.75 | -240.88 | Upgrade
|
| Free Cash Flow Margin | -19.78% | -9.57% | -15.90% | -75.12% | -94.34% | -133.97% | Upgrade
|
| Free Cash Flow Per Share | -1.51 | -0.81 | -1.30 | -5.33 | -7.51 | -8.46 | Upgrade
|
| Cash Interest Paid | 9.7 | 23.8 | 18.4 | 19.6 | - | - | Upgrade
|
| Cash Income Tax Paid | 5.05 | 5.05 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -42.4 | -45.37 | -49.09 | -80.59 | -120.24 | -130.31 | Upgrade
|
| Unlevered Free Cash Flow | -37.36 | -34.61 | -48.4 | -79.06 | -117.84 | -126.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.